The median (interquartile range) PMR levels of SFRP1, SFRP2, PRKCB and WIF1 in tumor tissues were 5.01% (2.32–15.82%), 15.00% (3.49–47.27%), 13.89% (6.89–24.57%) and 39.49% (22.21–76.05%), respectively, and in adjacent non-tumor tissues were 2.24% (1.12–3.46%), 7.17% (1.86–16.62%), 8.94% (4.30–15.17%) and 34.66% (18.04–58.69%), respectively. Here, SFRP1 is linked to neoplasm.